Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intraperitoneal chemotherapy and immunotherapy.

B E Wolf1, P H Sugarbaker

  • 1Health Science Center, University School of Medicine, Atlanta, GA 30322.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
Same author

Increased safety of surgical glove application: the under/over method.

Annals of the Royal College of Surgeons of England·2017
Same author

Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Management of an inguinal hernia in patients with pseudomyxoma peritonei.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Symptoms, signs and radiologic findings in patients having reoperative surgery for malignant peritoneal mesothelioma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
Same author

A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
Same journal

Future Challenges of Molecular Imaging in Oncology.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Clinical Applications of Theranostics.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Internal Radiation Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

The Role of Molecular Imaging in Ion Beam Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Molecular Imaging in Photon Radiotherapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Advancements in Intraoperative Imaging for Enhanced Surgical Precision.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
See all related articles

Intraperitoneal administration of antineoplastic drugs offers a kinetic advantage, achieving higher concentrations in the peritoneum than plasma. This localized delivery may reduce systemic toxicities, but its survival benefit requires further investigation.

Area of Science:

  • Pharmacokinetics
  • Drug Delivery Systems
  • Oncology

Background:

  • Intraperitoneal (i.p.) administration is a potential route for delivering antineoplastic drugs.
  • Understanding the pharmacokinetic profile of i.p. drug delivery is crucial for optimizing cancer therapy.

Purpose of the Study:

  • To validate a predictive model for i.p. drug administration.
  • To assess the pharmacokinetic advantage of i.p. delivery for antineoplastic agents.
  • To evaluate the potential for reducing systemic toxicities and improving survival rates.

Main Methods:

  • Empirical validation of a predictive pharmacokinetic model.
  • Comparison of drug concentrations in peritoneal fluid versus plasma following i.p. administration.

Related Experiment Videos

Main Results:

  • The predictive model was successfully validated empirically.
  • A significant kinetic advantage was observed for i.p. administration of certain antineoplastic drugs.
  • Peritoneal drug concentrations were orders of magnitude higher than plasma concentrations.

Conclusions:

  • Intraperitoneal administration of antineoplastic drugs provides a substantial pharmacokinetic advantage.
  • This localized delivery approach has the potential to mitigate rate-limiting systemic toxicities.
  • Further research is needed to determine if this advantage translates into improved patient survival.